195
Participants
Start Date
February 5, 2025
Primary Completion Date
January 31, 2028
Study Completion Date
June 30, 2028
Chiglitazar 64mg
Chiglitazar 64mg, oral, qd, for 72 weeks
Placebo
Placebo, oral, qd, for 72 weeks
Beijing Ditan Hospital, Capital Medical University, Beijing
Peking University People's Hospital, Beijing
Beijing Friendship Hospital, Capital Medical University, Beijing
Beijing Youan Hospital, Capital Medical University, Beijing
Beijing Ditan Hospital
OTHER
Peking University People's Hospital
OTHER
Beijing YouAn Hospital
OTHER
Beijing Friendship Hospital
OTHER